To evaluate the performance of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) for differentiating orbital malignant from benign tumors, and to assess the correlation between IVIM-DWI parameters and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters.Twenty-seven patients (17 benign and 10 malignant) with orbital tumors underwent 3.0T MRI examination for pre-treatment evaluation, including IVIM-DWI and DCE-MRI. IVIM-DWI parameters (tissue diffusivity, D; pseudo-diffusion coefficient, D; and perfusion fraction, f) were quantified using bi-exponential fitting model. DCE-MRI parameters (K, the volume transfer constant between the plasma and the extracellular extravascular space [EES]; Ve, the volume fraction of the EES, and Kep, the rate constant from EES to blood plasma) were quantified using modified Tofts model. Independent-sample t test, receiver operating characteristic curve analyses and Spearman correlation test were used for statistical analyses.Malignant orbital tumors showed lower D (P <.001) and higher D (P = .002) than benign tumors. Setting a D value of 0.966 × 10 mm/s as the cut-off value, a diagnostic performance (AUC, 0.888; sensitivity, 100%; specificity, 82.35%) could be obtained for diagnosing malignant tumors. While setting a D value of 42.371 × 10 mm/s as cut-off value, a diagnostic performance could be achieved (AUC, 0.847; sensitivity, 90.00%; specificity, 70.59%). Poor or moderated correlations were found between IVIM-DWI and DCE-MRI parameters (D and Kep, r = 0.427, P = .027; D and Ve, r = 0.626, P <.001).IVIM-DWI is potentially useful for differentiating orbital malignant from benign tumors. Poor or moderate correlations exist between IVIM-DWI and DCE-MRI parameters. IVIM-DWI may be a useful adjunctive perfusion technique for the differential diagnosis of orbital tumors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709032 | PMC |
http://dx.doi.org/10.1097/MD.0000000000014897 | DOI Listing |
BMC Cancer
January 2025
Department of Plastic Surgery, University of California, Irvine, CA, USA.
Background: While prosthesis-associated malignancies have been acknowledged, awareness among surgeons and patients in the ophthalmologic field remains limited, despite the frequent occurrence of prosthesis-related surgeries. We aim to address this gap through a scoping review of malignancies following ophthalmologic surgeries involving various foreign device/prosthesis/implants.
Methods: Following PRISMA guidelines, we conducted a review using PubMed and Embase for studies on cancer and ophthalmic prostheses/implants.
Radiology
January 2025
From the Departments of Radiology (V.K., A.R., P.D.) and Pathology (J.N.), University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR 72205.
A 61-year-old male patient without prior history of ophthalmologic problems presented with pain and redness in the left eye associated with slowly progressive proptosis over the previous 6 months. The patient also had diplopia in rightward and downward gaze. There was no vision loss.
View Article and Find Full Text PDFNPJ Digit Med
January 2025
Neurofibromatosis Type 1 Center and Laboratory for Neurofibromatosis Type 1 Research, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Deep-learning models have shown promise in differentiating between benign and malignant lesions. Previous studies have primarily focused on specific anatomical regions, overlooking tumors occurring throughout the body with highly heterogeneous whole-body backgrounds. Using neurofibromatosis type 1 (NF1) as an example, this study developed highly accurate MRI-based deep-learning models for the early automated screening of malignant peripheral nerve sheath tumors (MPNSTs) against complex whole-body background.
View Article and Find Full Text PDFAcute lymphoblastic leukemia (ALL) is a malignant condition of lymphoid progenitor cells that primarily affects the pediatric population, but also adults. The 5-year survival rate is 90% in children and approximately 40% in adults, with survival increasing through the use of peripheral stem cell allotransplantation (SCT). The relapse rate after stem cell transplantation (SCT) in adult acute lymphoblastic leukemia (ALL) patients ranges from 35% to 45%, making relapse a major cause of death in this population.
View Article and Find Full Text PDFMedicina (Kaunas)
December 2024
Department of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, 50-556 Wrocław, Poland.
Fibrous dysplasia is an uncommon bone disorder affecting various parts of the skeleton, often affecting facial and cranial bones. In this case, a 10-year-old patient was diagnosed with fibrous dysplasia of the ethmoid sinus at an early age. The patient has experienced nasal congestion, snores, and worsening nasal patency since 2019.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!